SIGN UP
LOG IN
T
TERN
Terns Pharmaceuticals, Inc.
3.44
-0.12-3.40%Opening13:07 05/02 EDT
OPEN/PREV CLOSE3.610/3.560
TODAY RANGE3.375-3.620
VOL928.33K
MARKET CAP300.36M
52 WEEK RANGE1.865-11.40
AVG VOL (3M)1.21M
% TURNOVER1.06%
TURNOVER--
P/E (TTM)-3.0775
% RANGE6.88%
EPS(TTM)-1.1175
P/E(FORWARD)-2.7735
P/B0.8663
BVPS3.970
DIVIDEND--
P/S283.18
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP273.70M
SHARES OUTSTANDING87.34M
NEXT EARNINGS05/12-05/16
FREE FLOAT79.58M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Viking among notable gainers as Pfizer raises deal prospects
Seeking Alpha·6d ago
Novo Nordisk: Examining Tariff And Pricing Risks
TipRanks·04/24 19:00
Biotech Alert: Searches spiking for these stocks today
NASDAQ·04/21 16:10
Monday Sector Leaders: Biotechnology, Drugs
Seeking Alpha·04/17 20:11
SA Asks: What's the best weight-loss drug stock right now?
TipRanks·04/15 10:17
Terns Pharmaceuticals (TERN) Gets a Buy from Mizuho Securities
Seeking Alpha·04/14 15:03
Viking, Structure, Metsera on a tear as Pfizer drops obesity pill
TipRanks·04/08 20:10
Terns Pharmaceuticals management to meet with Oppenheimer
Simply Wall St·03/31 10:24
Insider Purchases Worth US$5.17m See Losses As Terns Pharmaceuticals Market Value Drops To US$255m
TipRanks·03/24 11:55
Oppenheimer Remains a Buy on Terns Pharmaceuticals (TERN)
TipRanks·03/22 03:53
Terns Pharmaceuticals Reports 2024 Progress and Outlook
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.